Provectus Biopharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2017
Total Assets: $3.4M
Liabilities Breakdown FY2017
Total Liabilities: $13.5M
Asset Breakdown
Total Assets: $3.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $105.5K | 3.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $86.6K | 2.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $1.6M | 45.7% |
| Other Assets | $1.7M | 48.7% |
Liabilities Breakdown
Total Liabilities: $13.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.3M | 24.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $10.2M | 75.7% |